The one-day symposium will give an update on the current management of chronic Hepatitis B and C. The revolution started on the 1st March, with PSB listing of new medicines for HCV that achieve cure rates of more than 90-95% with only 12 weeks of well tolerated oral treatment for most. The management of Hepatitis B is also being refined.
The program includes lectures, panel discussions and interactive cases, which would provide general gastroenterologists, ID physicians and GPs with state of the art knowledge of how to treat HCV and HBV in primary and tertiary care settings.
Prof Norah Terrault
UCSF Liver Centre
University of California San Francisco
San Francisco, USA
Assoc. Prof John Lubel
Eastern Health & Monash University
St Vincent’s Hospital
27 Victoria Parade
8 am to 3:45 pm
Early bird registration opens Monday 12 September at 9am
For further information please contact Beverly Cooper (03) 9231 3581, or send an email